Clinical and Experimental Reproductive Medicine-CERM

Scope & Guideline

Transforming Knowledge into Practice in Reproductive Health

Introduction

Explore the comprehensive scope of Clinical and Experimental Reproductive Medicine-CERM through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinical and Experimental Reproductive Medicine-CERM in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2233-8233
PublisherKOREAN SOC REPRODUCTIVE MEDICINE
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 2011 to 2024
AbbreviationCLIN EXP REPROD MED / Clin. Exp. Reprod. Med.-CERM
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCHEIL MED RESEARCH INST BLDG 2F, CHEIL GENREAL HOSP, KWANDONG UNIV, COLL MED, SEOUL 100-380, SOUTH KOREA

Aims and Scopes

The journal "Clinical and Experimental Reproductive Medicine (CERM)" focuses on advancing the scientific understanding of reproductive medicine through a diverse range of studies. Its primary aim is to publish high-quality research that informs clinical practices and enhances reproductive health outcomes.
  1. Reproductive Health Research:
    CERM publishes studies related to reproductive health, including fertility, infertility treatments, and reproductive endocrinology, addressing both male and female reproductive systems.
  2. Innovative Treatment Modalities:
    The journal highlights novel therapeutic approaches and interventions in reproductive medicine, such as the use of stem cells, hormonal therapies, and nutritional supplements.
  3. Clinical and Experimental Studies:
    CERM features both clinical trials and experimental studies, bridging the gap between laboratory research and clinical applications to improve patient care.
  4. Metabolic and Genetic Factors in Reproduction:
    Research on the influence of metabolic syndromes and genetic predispositions on reproductive health is a key focus, exploring how these factors impact fertility and reproductive outcomes.
  5. Environmental and Lifestyle Impacts:
    The journal examines the effects of environmental toxins, lifestyle choices, and public health issues, such as the COVID-19 pandemic, on reproductive health.
CERM has recently seen a surge in research themes that reflect the latest advancements and emerging concerns in reproductive medicine. These trends indicate a shift towards integrating technology, personalized medicine, and holistic approaches to reproductive health.
  1. Metabolomics and Biomarkers:
    Research utilizing metabolomic profiling to identify biomarkers for fertility and reproductive health is on the rise, offering insights into personalized treatment strategies.
  2. Impact of COVID-19 on Reproductive Health:
    The pandemic has prompted increased studies examining the implications of COVID-19 on fertility, reproductive outcomes, and the safety of assisted reproductive technologies.
  3. Nutritional and Supplement Interventions:
    There is a growing emphasis on the role of dietary supplements and nutritional interventions in enhancing fertility and reproductive health, particularly in populations with specific deficiencies.
  4. Artificial Intelligence in Reproductive Medicine:
    The implementation of AI-driven technologies for optimizing IVF procedures and predicting patient outcomes is an emerging trend, showcasing the integration of technology in reproductive practices.
  5. Environmental and Lifestyle Influences:
    Research focusing on the effects of environmental factors, such as pollutants and lifestyle choices on reproductive health, is gaining traction, reflecting a broader awareness of public health issues.

Declining or Waning

While CERM continues to thrive in various research areas, certain themes are becoming less prominent in recent years. This decline may reflect evolving research interests or a shift towards more pressing issues in reproductive medicine.
  1. Traditional Pharmacological Interventions:
    Research focusing on conventional pharmacological treatments for reproductive health issues, such as hormone replacement therapies, appears to be waning as newer, more innovative treatments gain attention.
  2. Animal Model Studies:
    There is a noticeable decrease in studies solely reliant on animal models, indicating a shift towards human-centered research that prioritizes clinical relevance and applicability.
  3. Invasive Surgical Procedures:
    The exploration of invasive surgical techniques for fertility treatments is declining, likely due to advances in less invasive methods and the growing preference for minimally invasive approaches.

Similar Journals

Reproductive Medicine

Advancing Knowledge in Reproductive Health
Publisher: MDPIISSN: Frequency: 4 issues/year

Reproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.

International Journal of Reproductive Biomedicine

Connecting professionals with cutting-edge findings in biomedicine.
Publisher: SHAHID SADOUGHI UNIV MEDICAL SCIENCESISSN: 2476-4108Frequency: 12 issues/year

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

REPRODUCTION

Transforming research into reproductive health breakthroughs.
Publisher: BIOSCIENTIFICA LTDISSN: 1470-1626Frequency: 12 issues/year

REPRODUCTION, published by BIOSCIENTIFICA LTD, stands at the forefront of research in the fields of reproductive and developmental biology. With a focus on advancing our understanding of reproductive health and mechanisms, the journal has garnered an impressive reputation, consistently ranking in the first quartile for key categories including Embryology, Endocrinology, Obstetrics and Gynecology, and Reproductive Medicine in 2023. Notably, it holds an esteemed position in the Scopus rankings, with high percentiles that reflect its significant impact in the scientific community. The journal is committed to open access, promoting the broad dissemination of high-quality research to facilitate innovative discoveries and interdisciplinary collaboration. Situated in the United Kingdom, REPRODUCTION serves as a vital resource for researchers, professionals, and students eager to contribute to the evolving landscape of reproductive sciences and related fields.

Asian Pacific Journal of Reproduction

Empowering Researchers to Shape the Future of Reproduction
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2305-0500Frequency: 6 issues/year

Asian Pacific Journal of Reproduction is a dynamic open-access journal specializing in a diverse array of topics related to reproduction across various species, including humans, animals, and plants. Published by Wolters Kluwer Medknow Publications, this peer-reviewed journal has been committed to disseminating high-quality research since its inception in 2012. With an accessible ISBN of 2305-0500 and E-ISSN 2305-0519, the journal has rapidly established itself within the academic community, evidenced by its categorization in Q3 and Q4 quartiles across multiple fields, including Obstetrics, Gynecology, and Animal Science. Researchers are encouraged to contribute their findings to foster a deeper understanding of reproductive health and practices in the Asian Pacific region and beyond. The journal's inclusive scope and emphasis on interdisciplinary collaboration make it a crucial platform for professionals and scholars seeking to stay at the forefront of reproductive research.

Journal of the Endocrine Society

Empowering the endocrine community with open access insights.
Publisher: ENDOCRINE SOCISSN: Frequency: 12 issues/year

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

REPRODUCTIVE BIOMEDICINE ONLINE

Fostering excellence in reproductive medicine and scientific discourse.
Publisher: ELSEVIER SCI LTDISSN: 1472-6483Frequency: 14 issues/year

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

ENDOCRINE RESEARCH

Exploring innovative insights in hormonal research.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

FERTILITY AND STERILITY

Exploring breakthroughs in reproductive medicine.
Publisher: ELSEVIER SCIENCE INCISSN: 0015-0282Frequency: 12 issues/year

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

Hormone Molecular Biology and Clinical Investigation

Driving Innovation in Endocrine Research and Investigation
Publisher: WALTER DE GRUYTER GMBHISSN: 1868-1883Frequency: 12 issues/year

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

ANDROLOGIA

Leading the discourse in andrology and urological science.
Publisher: WILEYISSN: 0303-4569Frequency: 10 issues/year

ANDROLOGIA is a distinguished journal published by Wiley, focusing on the vital fields of andrology, urology, and endocrinology. Since its inception in 1969, this journal has become a key resource for researchers, clinicians, and students, striving to advance the understanding of male reproductive health and related disorders. With an impressive impact factor and recognition in category quartiles such as Q2 in both Medicine (miscellaneous) and Urology for 2023, ANDROLOGIA has established itself as a leading platform, ranking 16th out of 120 in Urology. Though not an open-access journal, it offers valuable insights through a rigorous peer-review process and a commitment to disseminating high-quality research. The journal's scope is broad, encompassing all aspects of andrology and its implications within medicine, ensuring it remains relevant to the evolving landscape of health sciences. Researchers looking to publish their work or keep abreast of recent discoveries will find ANDROLOGIA an essential addition to their academic resources.